Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 5.

Schreiner, B; Kieseier, B C; Hartung, H P; Hohlfeld, R; Wiendl, H (2005). Blockade von Adhäsionsmolekülen mit Natalizumab in der Therapie der Multiplen Sklerose. Aktueller Studienstand. Der Nervenarzt, 76(8):999-1005.

Wiendl, H; Feger, U; Mittelbronn, M; Jack, C; Schreiner, B; Stadelmann, C; Antel, J; Brueck, W; Meyermann, R; Bar-Or, A; Kieseier, B C; Weller, M (2005). Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. Brain: A Journal of Neurology, 128(Pt 11):2689-2704.

Mitsdoerffer, M; Schreiner, B; Kieseier, B C; Neuhaus, O; Dichgans, J; Hartung, H P; Weller, M; Wiendl, H (2005). Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis. Journal of Neuroimmunology, 159(1-2):155-164.

Schreiner, B; Mitsdoerffer, M; Kieseier, B C; Chen, L; Hartung, H P; Weller, M; Wiendl, H (2004). Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. Journal of Neuroimmunology, 155(1-2):172-182.

Paul, R; Koedel, U; Winkler, F; Kieseier, B C; Fontana, A; Kopf, M; Hartung, H P; Pfister, H W (2003). Lack of IL-6 augments inflammatory response but decreases vascular permeability in bacterial meningitis. Brain : a journal of neurology, 126(8):1873-1882.

This list was generated on Thu Oct 18 13:23:18 2018 CEST.